29 to 1.90). The presence of an ophthalmologist was significantly associated with a greater proportion of individuals with a college degree and health insurance, and more developed healthcare infrastructure. https://www.selleckchem.com/products/L-Adrenaline-Epinephrine.html From 1990 to 2017, the density of optometrists increased from 11.06 to 16.16 optometrists per 100,000 individuals. Conclusions and Relevance Over the last two decades, the national density of ophthalmologists has decreased and the workforce has aged. In contrast, the density of optometrists has increased. Rural counties continue to have a disproportionately lower supply of eye care providers, although some growth has occurred. Given the rising ratio of optometrists to ophthalmologists, it is of interest for future work to determine how the optometrist workforce can best complement potential shortages of ophthalmologists.Purpose To measure the magnitude and direction of anterior scleral canal opening (ASCO) offset relative to Bruch's membrane opening (BMO) (ASCO/BMO offset) in order to characterize neural canal obliqueness and minimum cross-sectional area (NCMCA) in 69 highly myopic and 138 healthy, age-matched, control eyes. Design Cross-sectional study. Methods Using Optic Coherence Tomography (OCT) scans of the optic nerve head (ONH), BMO and ASCO were manually segmented and their centroids, size and shape were calculated. ASCO/BMO offset magnitude and direction were measured after projecting the ASCO/BMO centroid vector onto the BMO plane. Neural canal axis obliqueness was defined as the angle between the ASCO/BMO centroid vector and the vector perpendicular to the BMO plane. NCMCA was defined by projecting BMO and ASCO points onto a plane perpendicular to the neural canal axis and measuring their overlapping area. Results ASCO/BMO offset magnitude was greater (highly myopic eyes, 264.3 ± 131.1 um; healthy controls, 89.0 ± 55.8 um, p less then 0.001, t-test) and ASCO centroid was most frequently nasal relative to BMO centroid (94.2% of eyes) in the highly myopic eyes. BMO and ASCO areas were significantly larger (P less then 0.001, t-test), NCMCA was significantly smaller (P less then 0.001), and all three were significantly more elliptical (P≤0.001) in myopic eyes. Neural canal obliqueness was greater in myopic (65.17º±14.03º) compared to control eyes (40.91º±16.22º; P less then 0.001, t-test). Conclusions Our data suggest that increased temporal displacement of BMO relative to the ASCO, increased BMO and ASCO area, decreased NCMCA and increased neural canal obliqueness are characteristic components of ONH morphology in highly myopic eyes.Purpose Analyze charts to determine patient outcomes operated with the perfluorooctane Ala® Octa compared to patient outcomes operated with perfluorodecaline F-Decalin. Design Retrospective, consecutive, comparative, interventional case series. Methods Forty-eight eyes that underwent vitrectomy with Ala® Octa were compared to 29 eyes that underwent vitrectomy with F-Decalin. Two experienced surgeons performed vitrectomies at the Geneva University Eye Clinic. Visual acuity before, at 8 and 24 weeks after surgery was documented and SD-OCT images were analyzed for abnormalities. Results Two patients experienced severe retinal toxicity including one with severe vision loss. However, no statistical difference in visual acuity was observed between Ala® Octa and F-Decalin. Analysis of SD-OCT images showed differences in occurrence of several abnormalities IS-OS alterations were found in 60.4% of Ala® Octa- and in 10.3% of F-Decalin-treated eyes, retinal atrophic areas in 41.7% of Ala® Octa and in none of F-Decalin, ILM contraction in 58.4% of Ala® Octa and in none of F-Decalin, inner retina cystic alterations in 58.3% in Ala® Octa and in 17.2% of F-Decalin, outer retina cystic alterations in 39.6% of Ala® Octa and in 13.8% of F-Decalin, retinal holes in 14,6% of Ala® Octa and in none of F-Decalin, outer retinal inclusions in 20,8% of Ala® Octa and in 3.45% of F-Decalin. Conclusion Ala® Octa has caused significantly more toxic damage than F-Decalin. Special consideration should be given to develop a central European control agency for medical devices and to reevaluate safety procedures currently accepted by the EU and ISO standard for intraocular surgery.Purpose To characterize the progression of optical gaps and expand the known etiologies of this phenotype. Design Retrospective cohort study. Methods Thirty-six patients were selected based on the identification of an optical gap on spectral-domain optical coherence tomography (SD-OCT) from a large cohort of patients (n=746) with confirmed diagnoses of inherited retinal dystrophy. The width and height of the gaps in 70 eyes of 36 patients were measured using the caliper tool on Heidelberg Explorer by two independent graders. Measurements of outer and central retinal thickness were also evaluated and correlated with gap dimensions. Results Longitudinal analysis confirmed the progressive nature of optical gaps in patients with Stargardt disease, achromatopsia, occult macular dystrophy, and cone dystrophies (p less then 0.003). Larger changes in gap width were noted in patients with Stargardt disease (78.1μm/year) and cone dystrophies (31.9μm/year) as compared to patients with achromatopsia (16.2μm/year) and occult macular dystrophy (15.4μm/year). Gap height decreased in patients with Stargardt disease (6.5μm/year) (p=0.02), but increased in patients with achromatopsia (3.3μm/year) and occult macular dystrophy (1.2μm/year). Gap height correlated with measurements of central retinal thickness at the fovea (r=0.782, p=0.00012). Interocular discordance of the gap was observed in 7 patients. Finally, a review of all currently described etiologies of optical gap was summarized. Conclusion The optical gap is a progressive phenotype seen in an increasing number of etiologies. This progressive nature suggests a use as a biomarker in the understanding of disease progression. Interocular discordance of the phenotype may be a feature of Stargardt disease and cone dystrophies.Purpose Indocyanine green angiography (ICGA) was compared with swept source optical coherence tomography angiography (SS-OCTA) for the detection of polypoidal choroidal vasculopathy (PCV). Design Retrospective, cross-sectional. Methods Patients with treatment-naïve PCV based on ICGA imaging underwent same day SS-OCTA imaging at Kyung Hee University Medical Center between April 2017 to November 2018. ICGA and SS-OCTA images were graded independently. SS-OCTA images were graded using both flow and structural information. Images were graded for the number of polypoidal lesions and the total lesion area, which included both the polypoidal lesions and the branching vascular networks (BVNs). Results A total of 31 eyes from 30 patients were enrolled. Polypoidal lesions were identified in all eyes using both modalities, and there was agreement on the number of polypoidal lesions in 17 eyes (55%). In 12 eyes (39%), SS-OCTA graders identified a greater number of polypoidal lesions, and in 2 eyes (6%), ICGA graders identified more lesions.